by Jordana Choucair | Nov 30, 2021 | D.C. News
The White House Office of Management and Budget (OMB) notified federal agencies that workers who do not comply with the administration’s COVID-19 vaccine requirement will not face serious penalties such as suspension or removal until January. Noting “tremendous...
by Jordana Choucair | Nov 29, 2021 | Public Health/Prevention
The World Health Organization (WHO) warned that the global risk of the omicron variant is “very high.” WHO urged member states to ramp up COVID-19 vaccinations “as rapidly as possible” and to shore up their virus surveillance and sequencing work. The...
by Jordana Choucair | Nov 29, 2021 | Life Sciences
A bipartisan group of 61 House members scolded the Biden administration for repealing a rule that would have required Medicare to pay for any medical device deemed as a “breakthrough” by the FDA. The CMS said that although the FDA reviews breakthrough...
by Jordana Choucair | Nov 29, 2021 | Life Sciences
BioNTech SE and Moderna Inc. are adjusting their COVID-19 vaccines to fight the omicron variant. BioNTech said it could have a new version of its shot ready within 100 days. The drugmakers are starting development as research continues on whether new shots are needed...
by Jordana Choucair | Nov 29, 2021 | Health IT
The Department of Health and Human Services warned health systems about the possibility of “zero-day attacks,” which occur when hackers weaponize an unknown flaw in a system and are often financially motivated. HHS said one vulnerability can put millions...
by Jordana Choucair | Nov 29, 2021 | D.C. News
The Supreme Court is set to hear arguments tomorrow in a case seeking to reverse cuts to the 340B Drug Program. The plaintiffs contend that if the court allows the rule to stand, “340B providers will be forced to eliminate or dramatically curtail some crucial programs...
Recent Comments